Clinical trial
The Potential Weight Loss Benefits of Rifaximin in an Intermittent Fasting Diet
NCT04674176 is registered in ClinicalTrials.gov with Bayhealth Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Potential Weight Loss Benefits of Rifaximin in an Intermittent Fasting Diet
- Lead sponsor
- Bayhealth Medical Center
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 1, 2021
- Completion date
- January 1, 2022
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.